Sending Office: Honorable Bobby L. Rush
Sent By:
Conor.Heffernan@mail.house.gov

        Request for Cosponsor(s)

Supported by: National Medical Association

Cosponsors (57): Adams, Bass, Barragán, Beatty, Sanford D. Bishop Jr., Blunt Rochester, Brown, Butterfield, Carson, Clarke, Clay, Clyburn, Cohen, Courtney, Danny K. Davis, Demings, Dingell, Evans, Fudge, Chuy Garcia,
Grijalva, Hastings, Horsford, Jackson Lee, Eddie Bernice Johnson, Henry C. “Hank” Johnson Jr., Robin L. Kelly, Khanna, Krishnamoorthi, Lawson, Barbara Lee, Lewis, McEachin, Moore, Morelle, Neguse, Norton, Payne, Plaskett, Pressley, Raskin, Richmond, Roybal-Allard,
Ruppersberger, Schakowsky, David Scott, Robert C. “Bobby” Scott, Serrano, Sewell, Sires, Slotkin, Soto, Bennie G. Thompson, Tlaib, Watson Coleman, Wild, Frederica S. Wilson

Dear Colleague:

Access to insulin can improve — and even save — countless lives.  That’s why in 1921, the scientists who isolated insulin sold the patent for this procedure to the University of Toronto for $3, and for decades, insulin was affordable
for those who relied on it.

A century later, skyrocketing costs are leading not only to extreme financial hardship for some of the most vulnerable Americans, but numerous untimely deaths due to insulin rationing.  Alec Smith could not afford his $1,300 monthly
medical bills.  He died 27 days after losing his health insurance at the age of 26.

Unfortunately, Alec is one of many.  According to the Centers for Disease Control, over 100 million Americans have diabetes or pre-diabetes, and Black, Hispanic, and American Indian/Alaskan Native populations are more likely to
be living with diabetes than White and Asian populations.  A study by The Lancet Diabetes & Endocrinology journal predicts that by 2030, 79 million adults with type 2 diabetes are expected to need insulin to manage their condition.  If current levels
of access remain, only half of them will be able to get an adequate supply.

That is why I have introduced
H.R. 366, the Insulin Access for All Act
.  This bill eliminates the cost-sharing requirement — including deductibles, copayments, and coinsurances — for insulin under both Medicare and Medicaid.

Diabetes is an epidemic, and we must ensure access to affordable medication for this disease.

I invite you to join me in cosponsoring the Insulin Access for All Act.  To learn more or to cosponsor, please contact Lauren Citron in my office at

Lauren.Citron@mail.house.gov
or 5-4372.

Sincerely,

Bobby L. Rush
Member of Congress

Related Legislative Issues

Selected legislative information: Family Issues, HealthCare

Related Bill Information

Bill Type: H.R.
Bill Type: 366
Special Note:

icon eDC logo e-Dear Colleague version 2.0
 
e-Dear Colleagues are intended for internal House use only.